96
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

ISOLATION AND PURIFICATION OF ECHINACOSIDE AND ACTEOSIDE FROM CISTANCHE TUBULOSA (SCHRENK) WIGHT BY HIGH-SPEED COUNTER-CURRENT CHROMATOGRAPHY

, , , , , & show all
Pages 2602-2609 | Published online: 05 Nov 2012
 

Abstract

Echinacoside and acteoside were isolated and purified from Cistanche tubulosa (Schrenk) Wight by one step of high-speed counter-current chromatography for the first time using a solvent system of ethyl acetate-n-butanol-glacial acetic acid-water (1:1.2:0.2:2, v/v/v/v). The experiment yielded 16.9 mg of echinacoside and 5.1 mg of acteoside from 220 mg of Cistanche tubulosa (Schrenk) Wight extract. The purity of the two compounds was 99.14% and 95.04%, respectively, as determined by HPLC. Their structures were identified by MS, UV, IR, and NMR analysis. Such a simple and effective method was fairly useful to prepare pure compounds as reference substances for related study on Cistanche tubulosa (Schrenk) Wight.

ACKNOWLEDGMENT

This work was supported by the International Scientific and Technological Cooperation Program of China (No: 2009DFA31230) and the Industry-University-Research Cooperation Program from Science and Technology Department of Guangdong Province (No: 2010B090400533).

Notes

Note. K, solute concentration in the upper mobile phase divided by that in the lower stationary phase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.